Cardior: Cardior Appoints Experts to its Scientific Advisory Board
HANOVER, Germany--(BUSINESS WIRE)-- Cardior Pharmaceuticals, a clinical-stage biotech company developing non-coding RNA (ncRNA)-based therapeutics for patients with cardiac diseases, today announced t...
Read full article »
Cardior is a Germany-based biopharmaceutical company that researches and develops RNA-dependent therapies for the treatment of heart diseases.
Read more